🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Trivalent split influenza vaccine (TIV)

Found 83 matching trials

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

PHASE2

Primary Objective: To evaluate for each influenza strain the non-inferiori...

Status

Completed

Location

Multiple Locations

Start Date

2006-10

Trial ID

NCT00391391

Treatments Being Tested

Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

PHASE3

This unblinded pilot study is intended to assess the feasibility of a large...

Status

Completed

Location

Mount Sinai Hospital

Start Date

2008-11

Trial ID

NCT00784784

Treatments Being Tested

Fluviral Zanamivir

Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)

PHASE3

The primary purpose of this study is to demonstrate the efficacy of an inve...

Status

Completed

Location

Multiple Locations

Start Date

2007-11

Trial ID

NCT00566345

Treatments Being Tested

Inactivated seasonal influenza vaccine (split virus, Vero cell-derived)Phosphate buffered saline

Immunogenicity and Safety of Different Doses of Fluzone® Influenza

PHASE2

The purpose of this research study is to find out if giving the smaller dos...

Status

Completed

Location

Saint Louis University

Start Date

2005-11

Trial ID

NCT00253734

Treatments Being Tested

Fluzone® (IM)Fluzone®

Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008

PHASE3

Annual trial for registration of trivalent split influenza vaccine with the...

Status

Completed

Location

Werksarztzentrum Herborn

Start Date

2007-06

Trial ID

NCT00498303

Treatments Being Tested

trivalent split influenza vaccine

A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

PHASE2

The purpose of this study is to generate data on immunogenicity and safety ...

Status

Completed

Location

Multiple Locations

Start Date

2009-08

Trial ID

NCT00956202

Treatments Being Tested

Swine A/H1N1 influenza vaccine (split virion, inactivated)Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)

Immunogenicity of Influenza Vaccines in HIV-infected Persons in Thailand

PHASE4

This study will assess the efficacy of a new intradermal formulation of the...

Status

Completed

Location

Silom Community Clinic

Start Date

2011-11-01

Trial ID

NCT01538940

Treatments Being Tested

Intradermal vaccine Intramuscular vaccine

Study to Evaluate Immunogenicity and Safety of a High-Dose Influenza Vaccine in Adults 50 Through 64 Years of Age

PHASE3

The purpose of this study is to evaluate Immunogenicity and Safety of a Hig...

Status

Completed

Location

CenExel CNS- Site Number : 8400005

Start Date

2024-11-04

Trial ID

NCT06641180

Treatments Being Tested

High-Dose trivalent influenza vaccine (Split virion, Inactivated)Standard-dose trivalent influenza vaccine (Split virion, Inactivated)

A Phase III Clinical Trial of An Inactivated Quadrivalent Influenza Vaccine in Healthy Subjects Aged 3 Years and Older

PHASE3

Influenza is an acute respiratory disease caused by influenza viruses. Ther...

Status

Completed

Location

Guanyun County Center for Disease Control and Prevention

Start Date

2016-01

Trial ID

NCT02710409

Treatments Being Tested

Quadrivalent influenza vaccine Trivalent influenza vaccine A Trivalent influenza vaccine B

A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine

PHASE1

This is a phase I, double-blind, randomized, placebo-controlled trial with ...

Status

Completed

Location

Clinical Center of Serbia

Start Date

2015-11

Trial ID

NCT02585700

Treatments Being Tested

Influenza vaccine, split inactivated Placebo

Previous Next